Projects overview

Sort by


Show more information
Title Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic
Description health preparedness and response to COVID-19.
 Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020 Result title Absence of association between 2019‐20 influenza vaccination and COVID19: Results of the European I‐MOVE‐COVID19 primary care project, March‐August 2020 Result comments I-MOVE-COVID-19 Result acronym I-MOVE-COVID-19-722372
 Periodic Reporting for period 1 - I-MOVE-COVID-19 (Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic) Result description Objective of proposal: We aim to obtain epidemiological, clinical and virological information about COVID-19 and patients infected with COVID-19, through provision of a flexible surveillance platform Result comments I-MOVE-COVID-19
 WP2 Surveillance monitoring and evaluation protocol Result comments I-MOVE-COVID-19
 Surveillance monitoring and evaluation protocol Result comments I-MOVE-COVID-19
 Website Result comments I-MOVE-COVID-19
 Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study Result comments I-MOVE-COVID-19
 Protocols for priority studies later in the epidemic Result comments I-MOVE-COVID-19
 Study reports on priority studies early in the epidemic Result comments I-MOVE-COVID-19
 WP2 Second surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers Result comments I-MOVE-COVID-19
 WP2 First surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 First surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 Pooled database for clinical samples Result comments I-MOVE-COVID-19
 Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR Result comments I-MOVE-COVID-19
 Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain Result comments I-MOVE-COVID-19
 Second surveillance bulletin including data from all sentinel sites Result comments I-MOVE-COVID-19
 Independent Role of Severe Obesity as a Risk Factor for COVID‐19 Hospitalization: A Spanish Population‐Based Cohort Study Result comments I-MOVE-COVID-19
 Hospital Phased surveillance protocol Result comments I-MOVE-COVID-19
 First Report Steering-Scientific Committee, scientific meeting Result comments I-MOVE-COVID-19
 Report to identify synergies and areas for collaboration Result comments I-MOVE-COVID-19
 Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study Result comments I-MOVE-COVID-19
 Protocols for priority studies early in the epidemic Result comments I-MOVE-COVID-19
 Phased surveillance protocol Result comments I-MOVE-COVID-19
 Report describing existing information on COVID-19 and knowledge gaps and recommendations on short-term and longer-term priority studies. Result comments I-MOVE-COVID-19
 Report kick-off ST-SC Committee meeting Result comments I-MOVE-COVID-19
 Report describing current COVID-19 surveillance practices and recommendations Result comments I-MOVE-COVID-19
 Interim activity Report Result comments I-MOVE-COVID-19
 Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 Result comments I-MOVE-COVID-19
 Report describing current COVID-19 hospital surveillance practices Result comments I-MOVE-COVID-19
Show more information
Title Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques
Description The COVID-19 and a long list of potential clients contacting us for a solution made us prioritize the detection of COVID-19.
 Periodic Reporting for period 1 - NanoScent COVID-19 (Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques) Result title Periodic Reporting for period 1 - NanoScent COVID-19 (Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques) Result description To contain the COVID-19 pandemic, the WHO has published travel advice for international traffic. Result comments NanoScent COVID-19
 Continuous Report on Communication and Commercialization Activities Result comments NanoScent COVID-19 Result acronym NanoScent COVID-19-717075
 Project QA Handbook Result comments NanoScent COVID-19
 Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds Result comments NanoScent COVID-19
Show more information
Title COVID-19 ICU-CARE – A ground-breaking ICU bed-side COVID-19 trachea flushing system that can cut healthcare costs and reduce COVID-19 spread between ICU patients and staff
Description The aim of this project is to take TrachFlush to market and battle the COVID-19 outbreak.
 Periodic Reporting for period 1 - COVID-19 ICU-CARE (COVID-19 ICU-CARE – A ground-breaking ICU bed-side COVID-19 trachea flushing system that can cut healthcare costs and reduce COVID-19 spread between ICU patients and staff) Result title Periodic Reporting for period 1 - COVID-19 ICU-CARE (COVID-19 ICU-CARE – A ground-breaking ICU bed-side COVID-19 trachea flushing system that can cut healthcare costs and reduce COVID-19 spread between Result description Problem:When the severely ill COVID-19 patients are admitted to the Intensive Care Unit (ICU) for respiratory support (breathing with the support of a mechanical ventilator), it is crucial that the upper Result comments COVID-19 ICU-CARE Result acronym COVID-19 ICU-CARE-787997
Show more information
Description The coronavirus outbreak will further increase this number dramatically as COVID-19 often leads to MOF.
 Periodic Reporting for period 1 - ADVOS-COVID-19 (Increasing Survival of Patients with Severe SARS-CoV-2 Infection and/or Multi Organ Failure by up to 30% with ADVOS - ADVanced Organ Support) Result title Periodic Reporting for period 1 - ADVOS-COVID-19 (Increasing Survival of Patients with Severe SARS-CoV-2 Infection and/or Multi Organ Failure by up to 30% with ADVOS - ADVanced Organ Support) Result description ADVITOS` innovation – the ADVOS therapy system - has the potential to increase the survival of COVID-19 patients suffering from severe multi organ failure (MOF). Result comments ADVOS-COVID-19 Result acronym ADVOS-COVID-19-748536
Show more information
Title Rapid COVID-19 Passive Therapy Response Platform
Description COVID-19 is a global health problem and we need to be ready for this.
 Periodic Reporting for period 1 - RapCo-19 (Rapid COVID-19 Passive Therapy Response Platform) Result title Periodic Reporting for period 1 - RapCo-19 (Rapid COVID-19 Passive Therapy Response Platform) Result description COVID-19 continues to be a global health problem over a year after the initial outbreak. The original scope of the project was to provide a fully validated process to use...
Show more information
Title Antibody therapy against coronavirus (COVID-19)
Description ATAC aims at developing passive immunotherapy against COVID-19.
 Antibody therapy for COVID-19 Result title Antibody therapy for COVID-19
 Periodic Reporting for period 1 - ATAC (Antibody therapy against coronavirus (COVID-19)) Result description The emergence and spread of the novel human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19), has led to a pandemic with major
Show more information
Title Optimal use of hospital resources and intervention using suPAR for improving prognosis and care for patients with COVID-19
Description COVID-19 and thereby select which patients that could be discharged or admitted.
 Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI Result title Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
 Periodic Reporting for period 1 - RISCinCOVID (Optimal use of hospital resources and intervention using suPAR for improving prognosis and care for patients with COVID-19) Result description The issue being addressed in this project is to provide tool for better handling of COVID-19: How we can improve prognosis and care for patients with COVID-19 and, at the same time, optimize hospital resources
Show more information
Title AI software for the automated detection of covid-19 infection on chest CT
Description An AI platform to support medical practitioners to screen potential COVID-19 patients using medical imaging.
 Periodic Reporting for period 1 - CoronAI (AI software for the automated detection of covid-19 infection on chest CT) Result title Periodic Reporting for period 1 - CoronAI (AI software for the automated detection of covid-19 infection on chest CT) Result description Aidence is creating a new product to automatically analyse chest CT scans and diagnose the presence of corona (covid-19) viral infection.
Show more information
Title Harmless Respiration for Intensive Care Patients decreasing mortality and shortening stays – including COVID-19 patients
Description The current outbreak of COVID-19 is incisively pointing towards the importance of optimal mechanical ventilation in Intensive Care. Improved mechanical ventilation saves lives.
 A case report of individualized ventilation in a COVID-19 patient – new possibilities and caveats to consider with flow-controlled ventilation Result title A case report of individualized ventilation in a COVID-19 patient – new possibilities and caveats to consider with flow-controlled ventilation
 Periodic Reporting for period 1 - Jane (Harmless Respiration for Intensive Care Patients decreasing mortality and shortening stays – including COVID-19 patients) Result description The outbreak of COVID-19 is incisively pointing towards the importance of optimal mechanical ventilation in the Intensive Care Unit (ICU). Improving mechanical ventilation saves lives.
Show more information
Title SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe
Description Coronavirus disease 19 (COVID-19) is provoking the greatest global health crisis of this generation.
 Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19–Convalescent Donors Result title Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19–Convalescent Donors
 Periodic Reporting for period 1 - SUPPORT-E (SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe) Result description SUPPORT-E brings together major European Blood Establishments (BEs) with world leading research capabilities with the aim to support high quality clinical and scientific evaluation of COVID-19 Convalescent
Show more information
Title Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).
Description The accumulation of fluid in the lungs is a significant feature of the pathology in patients with severe Covid-19 infection.
 'Oral imatinib in severe Covid-19' study peer reviewed publication Result title 'Oral imatinib in severe Covid-19' study peer reviewed publication
 Periodic Reporting for period 1 - Impentri (Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).) Result description The Impentri IMI2 consortium was awarded a €3.6M grant, to re-purpose an existing licensed oncology drug, imatinib for the treatment of Acute Respiratory Distress Syndrome (ARDS) induced by COVID-19.
Show more information
Title Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.
Description The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time.
 Periodic Reporting for period 1 - INNO4COV-19 (Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.) Result title Periodic Reporting for period 1 - INNO4COV-19 (Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.) Result description The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time.
Show more information
Title Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic
Description The mission of RESPOND is 1) to identify critical resilience factors and specific vulnerable groups at risk of immediate and long-term adverse mental health impact of the COVID-19 pandemic; 2) To improve
 Rapid report on vulnerable groups for COVID-19 related psychological distress Result title Rapid report on vulnerable groups for COVID-19 related psychological distress Result description Vulnerable groups for COVID-19 related psychological distress (anxiety, depression, symptoms of posttraumatic stress disorder) will be identified based on cohort studies in WP2.
Show more information
Description -19 disease.
 Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape Result title Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape
 Periodic Reporting for period 1 - icovid (AI-based chest CT analysis enabling rapid COVID diagnosis and prognosis) Result description The impact COVID-19 has on health care systems and society as a whole is enormous.
Show more information
Title A diagnostic test to improve surveillance and care of COVID-19 patients
Description Being able to identify COVID-19 patients at risk of developing cardiovascular events leading to death would allow improving surveillance and care.
 Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Result title Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors.
Show more information
Title Unravelling Data for Rapid Evidence-Based Response to COVID-19
Description unCoVer is a functional network of research institutions collecting data derived from the provision of care to COVID-19 patients by health systems across Europe and internationally.
 Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol Result title Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol
Show more information
Title COVID-19-Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research
Description Among the biggest challenges in the COVID-19 outbreak are the lack of triangulation of clinical, epidemiologic and immunological information for evidence- based response strategies.
 Key questions for modelling COVID-19 exit strategies Result title Key questions for modelling COVID-19 exit strategies
Show more information
Description ACE2 is also the key receptor for SARS-CoV-2 Spike protein and has got centre stage for novel therapies and a fundamental understanding of COVID-19.
 Human recombinant soluble ACE2 in severe COVID-19 Result title Human recombinant soluble ACE2 in severe COVID-19
 Periodic Reporting for period 1 - MAD-CoV 2 (Modern approaches for developing antivirals against SARS-CoV 2) Result description The MAD-CoV 2 project is a collaboration of world-leading researchers and innovative industry partners that aims to develop and deliver treatment for COVID-19 patients, significantly increasing the capacity
Show more information
Description Since the beginning of the pandemic XENOTHERA has initiated a project to develop a new treatment against COVID-19 based on its technology.
 Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial Result title Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
 Periodic Reporting for period 1 - BRIGHT (Treat severe cases of infection at COV with XAV-19) Result description The issue addressed in BRIGHT by XENOTHERA is the treatment of coronavirus disease 2019 (COVID-19). The goal is to reduce progression of mild to severe disease.
Show more information
Title Kahun - an interactive medical knowledge base, for modeling medical knowledge and managing diagnostic processes, as well medical knowledge related to COVID-19.
 Launch “COVID-19” dedicated web based map/symptomizer Result title Launch “COVID-19” dedicated web based map/symptomizer Result description We intend to develop a “COVID-19” dedicated symptomizer, which will help physicians in assessing patients and considering their match against a match with other diseases which come up with the COVID-19
Show more information
Title reDucing the health and Economic COst of Diagnostic uncErtainty: establishing potential applications of BV™ and its composite biomarkers in COVID-19 detection and patient management
Description To deploy BV™/Key™ at hospitals in Israel, Germany and Italy that are managing COVID-19 patients. 2.
 Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19 Result title Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19
Show more information
Title COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus
Description As we currently experience with the COVID-19 pandemic, bioagents can cause enormous societal and economic damage.
 Periodic Reporting for period 1 - ABwipe (COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus) Result title Periodic Reporting for period 1 - ABwipe (COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus)
Show more information
Title Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits
Description CORONADX will provide one “front line” and two “second line” diagnostic tools for COVID-19.
 Periodic Reporting for period 1 - CORONADX (Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness, public health and socio-economic benefits) Result title Periodic Reporting for period 1 - CORONADX (Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 CoronaThree Rapid Diagnostic tests (Point-of-Care) for Coronavirus, improving epidemic preparedness
Show more information
Title Non-intended health, economic and social effects of the COVID-19 epidemic control decisions: Lessons from SHARE (SHARE-COVID19)
Description The non-intended consequences of the epidemic control decisions to contain the COVID-19 pandemic are huge and affect the well-being of European citizens in terms of economics, social relationships and
 Sex differences in activity and health changes following COVID-19 in Europe—results from the SHARE COVID-19 survey Result title Sex differences in activity and health changes following COVID-19 in Europe—results from the SHARE COVID-19 survey
Show more information
Title PORTABLE PLATFORM FOR THE ASSESSMENT OF MICROVASCULAR HEALTH IN COVID-19 PATIENTS AT THE INTENSIVE CARE
Description As COVID-19 spreads worldwide, the surge in patients requiring intensive care unit (ICU) admission has been overwhelming to the healthcare systems.
 Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units Result title Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units
Show more information
Title Video Livestreaming Has Never Been Easier And Can Help Us Stay Connected During COVID-19
Description Contentflow provides a complete livestreaming platform ranging from a single hub for Contentflow is already in the process of assisting in the critical situation with COVID-19.
 Periodic Reporting for period 1 - Contentflow (Video Livestreaming Has Never Been Easier And Can Help Us Stay Connected During COVID-19) Result title Periodic Reporting for period 1 - Contentflow (Video Livestreaming Has Never Been Easier And Can Help Us Stay Connected During COVID-19)
Show more information
Title Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics
Description In epidemic-like situations such as COVID-19, SEPSIS is prevalent in >60% of the admitted patients and all non-survivors had SEPSIS.
 Periodic Reporting for period 1 - RAPID-SEP-AST (Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics) Result title Periodic Reporting for period 1 - RAPID-SEP-AST (Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics)